NBOG focus turns to notified body role in new and revised regulations
This article was originally published in RAJ Devices
Following the publication of a number of key documents related to how notified bodies should audit their medical device clients1, the European Commission’s Notified Bodies Operations Group is now anticipating the planned revision of the In Vitro Diagnostics Directive (Directive 98/79/EC)2. It is looking at conformity assessment and related notified body issues within this context.
You may also be interested in...
With just over 100 days to go until the full application of the EU Medical Device Regulation, notified body designations are trickling through. Ireland is the latest to now have a resident EU MDR notified body.
In this second article of a two-part series, Eithne Lee of ISO Life Sciences global consultancy identifies some of the problems that medtech premarket innovators and SMEs are facing, with the EU MDR application date now less than four months away.
The EU Medical Device Regulation threatens the viability of many premarket innovators and SMEs in the UK, and across Europe. Eithne Lee, of ISO Life Sciences global consultancy, explains how the new requirements come as a shock for many small companies, how many are ill-prepared and how the cost of compliance relative to turnover may be too high. This is part one of a two-part article.